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MOST workers interested in the role of pituitary hormones in the induction of
tumours by carcinogenic compounds or by X-rays have studied these processes
in hypophysectomized animals. Bickis, Estwick and Campbell (1956) availed
themselves of another experimental tool, the pituitary dwarf mouse. In this
animal dwarfism is due to a genetical defect. The acidophil cells are absent from
the adenohypophysis which consequently fails to secrete growth hormone in
measurable amounts.
Published results indicate that the effect ofhypophysectomy on carcinogenesis
is not uniform. In the absence of the pituitary azo dyes and aminofluorene
derivatives fail to induce liver tumours (Griffin, Rinfret and Corsiglia, 1953;
O'Neal, Hoffman, Dodge and Griffin, 1958) whereas carcinogenesis by locally
acting hydrocarbons (Korteweg and Thomas, 1939) and the induction oflymphoid
tumours by X-rays (Nagareda andKaplan, 1954) is not inhibited. It was therefore
surprising that Bickis et al. (1956) obtained only one benign skin tumour in dwarf
mice with doses of methylcholanthrene which induced more than 60 per cent
of carcinomas in the phenotypically normal controls.
In the present paper we submit the results obtained by the subcutaneous
injection of methylcholanthrene into pituitary dwarf mice.
MATERIALS AND METHODS
In 1955 Dr. R. Ortman brought mice carrying thegene responsible for pituitary
dwarfismfromCaliforniatothe MedicalSchool, Dunedin. Thedwarfsoftheimported
stock had a rather short life span. Therefore one male and one female known to
be heterozygous for the dwarfgene were crossed to animals of our NZY and NZC
strains. Offspring of these outcrosses were used. They were two to three months
old at the beginning of the experiment. Litter mates of normal phenotype and of
the same sex served as controls to the dwarfs. The average weight of the latter
was 6 g. and of the former 25 g.
The animals were kept in metal boxes. A perspex covered inset and cellulose
wadding was provided for the dwarfs. The mice were fed ground wheat and a
mash consisting of wheat germ 200 g., dried skimmed milk 1250 g., dried yeast
250 g., pollard 400 g., cod liver oil 100 ml., butter 225 g., iodized salt 100 g. and
ferrous sulphate 5 g., supplemented once weekly by greens, meat meal and lightlyCARCINOGENESIS IN PITUITARY DWARF MICE
boiled liver. Under these conditions the dwarfs have as long a life span as normal
sized mice.
Methylcholanthrene was administered as a 0.5 per cent solution in olive oil.
Each mouse received one dose of 0.1 ml. by subcutaneous injection.
In order to ascertain that the typical pituitary defect was present in all dwarfs
their pituitaries were studied histologically. The following staining methods
were used: for acidophils Crossmon's (1937) modification of the Mallory stain
and Green's (1951) method; for basophils the PAS procedure, and fuchsin-
aldehyde for the demonstration of thyrotrophs. Other tissues were stained with
haematoxylin-eosin or according to van Gieson; for melanin the Masson-Fontana
method was used.
RESULTS
The study of the endocrine organs of our dwarfs has assured us that they
conform in all essential characters to the classical picture as reviewed by Griine-
berg (1952). Already the pioneer work ofSnell (1930) andofSmithandMacDowell
(1930, 1931) established that pituitary dwarf mice suffer not only from lack of
growth hormone but that other endocrine deficiencies are also present. Most
observers were impressed by the underdevelopment of the thyroid and the
immaturity of the gonads, especially of the ovaries. Recently Ortman (1956)
discovered that the adenohypophysis of the dwarf contains few thyrotrophs, an
observation fully confirmed in our material (Fig. 1, 2).
Since we were unable to find in the literature data on the caloric intake of
pituitary dwarf mice, a factor of some importance in carcinogenesis, we have
checked their food consumption and found that per gram body weight the dwarfs
have a greater intake than their phenotypically normal litter mates. Seven
female dwarfs with an average weight of 8.2 g. and 7 sisters of normal phenotype
with an average weight of 24-5 g. were placed for 2 periods of 72 hours each into
metabolic cages and fed on whole wheat grain and reconstituted full cream milk.
The values given inTable I are expressed as calories per 10g. bodyweight/24hours.
TABLE I.-Food Intake ofPituitary Dwarfs and Phenotypically normal Litter Mates
(Calories*/10 g. body weight/24 hours)
Experiment Experiment
I Wheat Milk Total II Wheat Milk Total
Dwarfs . 9-41 . 0- 66 . 10.-07 Dwarfs 8-13 . 0-65 . 8 - 78
Normals. . 4.49 2-07 . 6 56 Normals . 4- 32 2.50 . 6 82
* 100 g. wheat = 362 calories (Sherman, 1941).
100 g. whole dried milk = 530 calories (McCance and Widdowson, 1942).
In order to test the toxicity of methylcholanthrene for dwarfs five animals
were injected with 0.5 mg. ofthe carcinogen. There was no serious loss ofweight.
Within 105 days three ofthese mice developed sarcomas at the site of application.
The two other animals were killed at 300 and 325 days when they were still in
good condition. No neoplastic lesions were found at autopsy.
Table II summarizes the results obtained in 12 dwarfs and 10 controls injected
with 0.5 mg. of methylcholanthrene. Tumour development occurred in both
groups with about equal speed and there was no difference in incidence. Therefore
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it was not considered necessary to increase the number of experiment animals.
The first lesion to be noted in a dwarf and in a phenotypically normal animal
originated in the epidermis. In the latter apapilloma arose at the site ofinjection:
it progressed to an invasive carcinoma. The dwarf lived for only one week after
the lesion was discovered. The short time ofsurvival does not allow an assessment
ofthe potentialities ofthe benign neoplastic changes found at autopsy in epidermis
and hair follicles (Fig. 3). Only one further epithelial tumour was found, a mam-
mary carcinoma occurring in a female control (No. 8). All other neoplasms were
sarcomas. They invaded without exception the muscles of the abdominal wall
and often also the panniculus carnosus. Some of the sarcomas grew with extra-
ordinary speed. For instance in dwarf 17 the tumour was discovered 8 days
before the animalwas killed. At autopsy the bodyweight was 7.5g. andthe weight
of the tumour 735 mg. Macroscopically recognizable areas ofhyperpigmentation
were found in two dwarfs. They were due to an increase of melanocytes in the
epidermis and to an accumulation of melanophores in the subepithelial layers of
the dermis. A casual inspection ofsections showing sarcoma cells in closeproximity
with melanophores may have suggested the diagnosis melanoma. However,
melanin containing cells were found only between epidermis and panniculus
carnosus and never in the subcutis (Fig. 4 and 5).
TABLE II.-Tumours Induced by Methylcholanthrene in Pituitary Dwarfs and
Phenzotypically Normal Litter Mates
Duration Duration
Dwarf (days) Tumour Control (days) Tumour
19 3 32* - - - -
27 9 . 59 .. Epithelioma 16 9 . 46 . Ca. of skin
8 · 79 . Sarcoma 24 c3 · 72 . Sarcoma
16? . 86 . ,, 9 . 86 . ,,
9 d . 86 . ,, 28 . 86 . ,,
24 3 . 86 . ,, 15 . 100 . ,,
25 3 . 93 . ,, 27 9 . 113 . ,,
266 . 100 . ,, 8 9 . 120 . Mammary Ca.
18 d . 108 . ,, 18 S . 177 . Sarcoma
28 . 156 . ,, 19 . 275
23 . 268 . - 176 . 275 -
15? . 275 . - -
Corresponding numbers indicate litter mates; No. 18 also litter mate of No. 17; No. 24 also of
No. 25 + 26.
Duration = tumour first palpated or killed to terminate experiment.
* Died.
EXPLANATION OF PLATES
FIo. 1.-Pituitary of dwarf showing half of anterior lobe with very few small thyrotrophs
(dark cells). Fuchsin-aldehye-Haematoxylin. x 120.
FIG. 2.-Central area of anterior lobe of phenotypically normal mouse. Note the numerous
dark thyrotrophs. Fuchsin-aldehyde-Haematoxylin. x 120.
FIG. 3.-Benign epithelial lesion (dwarf No. 27). H. and E. x 100.
FIG. 4.-Accumulation ofmelanophores in dermis which is invaded by sarcoma (dwarfNo. 16).
Silver-Haematoxylin. x 100.
FIG. 5.-Central part of sarcoma Fig. 4. H. and E. x 100.
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DISCUSSION
From the results presented it is evident that the action ofmethylcholanthrene
on connective tissue cells ofthe subcutis is not modified by an endocrine imbalance
characterized by lack of growth hormone, thyroid deficiency and hypogonadism.
Since stainable acidophils are absent from the adenohypophysis of dwarfs these
animals lack probably also prolactin. A comparison of our findings with those
obtained in the hypophysectomized rat shows good agreement with the work of
Zamurovitch (1953) and of Agate, Antopol, Glaubach, Agate and Graff (1955)
who observed that formation of sarcomas induced by benzpyrene proceeded
unimpeded in the absence of the pituitary. In contrast Moon and Simpson (1955)
found in two experiments a marked inhibition of the carcinogenic action of
injected methylcholanthrene after ablation of the pituitary, a discrepancy which
is unexplained at present. Under our experimental conditions not even a signifi-
cant retardation of tumour development was apparent as was noted by Noble
and Walters (1954) in hypophysectomized rats injected with dimethyl-benz-
anthracene.
SUMMARY
Sarcomas induced by subcutaneous injection of methylcholanthrene develop
in pituitary dwarf mice in the same manner as in their phenotypically normal
litter mates.
REFERENCES
AGATE, F. J. Jr., ANTOPOL, W., GLAUBACH, S., AGATE, F. AND GRAFF, S.-(1955)
Cancer Res., 15, 6.
BICKIS, I., ESTWICK, R. R. AND CAMPBELL, J. S.-(1956) Cancer, 9, 763.
CROSSMON, S.-(1937) Anat. Rec., 69, 33.
GREEN, J. D.-(1951) Amer. J. Anat., 88, 225.
GRIFFIN, A. C., RINFRET, A. P. AND CORSIGLIA, V. F.-(1953) Cancer Res., 13, 77.
GRiJNEBERG, H.-(1952) 'The Genetics of the Mouse'. The Hague (Martinus &
Nighoff).
KORTEWEG, R. AND THOMAS, F.-(1939) Amer. J. Cancer, 37, 36.
MCCANCE, R. A. AND WIDDOWSON, E. M.-(1942) Spec. Rep. Ser. med. Res. Coun. Lond.,
235, 31.
MOON, H. D. AND SIMPSON, M. E.-(1955) Cancer Res., 15, 403.
NAGAREDA, S. AND KAPLAN, H. S.-(1954) Proc. Amer. Ass. Cancer Res., 1 (2), 34.
NOBLE, R. L. AND WALTERS, J. H.-(1954) Ibid., 1 (2), 35.
O'NEAL, M. A., HOFFMAN, H. E., DODGE, B. G. AND GRIFFIN, A. C.-(1958) J. nat.
Cancer Inst., 21, 1161.
ORTMAN, R.-(1956) J. Morph., 99, 417.
SHERMAN, H. C.-(1941) 'Chemistry of Food and Nutrition'. New York (The Mac-
millan Company), p. 560.
SNELL, G. D.-(1930) Anat. Rec., 47, 316.
SMITH, P. E. AND MACDOWELL, E. C.-(1930) Ibid., 46, 249.-(1931) Ibid., 50, 85.
ZAMUROVITCH, D. A.-(1953) Oncologia, 6, 190.